Clinical trial · Interventional
PRISM for Parents of Children With Cancer Promoting Resilience in Stress Management (PRISM) Intervention for Parents of Children With Cancer
A Pilot Randomized Controlled Trial of the Promoting Resilience in Stress Management (PRISM) Intervention for Parents of Children With Cancer
NCT02998086CI-TRIAL-00050724completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Parenting a child with cancer is highly stressful. The investigators have designed a promising parent-centered intervention to bolster parent resilience and reduce stress and distress. This study will test 2 formats of the intervention (individual or group-based) and compare them to usual care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Promoting Resilience in Stress Management | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Individual (1:1)
- description
- Individual, 1:1 version of the Promoting Resilience in Stress Management for Parents (PRISM-P) intervention
- interventionNames
- Behavioral: Promoting Resilience in Stress Management
- type
- EXPERIMENTAL
- label
- Group
- description
- Group-based version of the Promoting Resilience in Stress Management for Parents (PRISM-P) intervention
- interventionNames
- Behavioral: Promoting Resilience in Stress Management
- type
- NO_INTERVENTION
- label
- Usual Care
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Parents of children who: * Are aged 2-24 years * Have been diagnosed with new malignancy between 1-10 weeks prior * Are scheduled to receive cancer-directed therapy at Seattle Children's Hospital * Has provided written informed consent (child aged 18 years and older), written assent (child aged 13-17 years), verbal assent (child aged 7-12 years). * Able to speak and read English language * Cognitively able to participate in interactive interviews Exclusion Criteria: * Parent is \< 18 years of age * Parent is cognitively or physically unable to participate in interactive interview * Parent is unable to speak and read English language * Parent or child participated on prior PRISM intervention study
References
Publications (2)
- DERIVEDRosenberg AR, Zhou C, Bradford MC, Barton K, Junkins CC, Taylor M, Kross EK, Curtis JR, Dionne-Odom JN, Yi-Frazier JP. Parent Perspectives after the PRISM-P Randomized Trial: A Mixed-Methods Analysis. J Palliat Med. 2021 Sep;24(10):1505-1515. doi: 10.1089/jpm.2020.0720. Epub 2021 Mar 15. PMID 33720787
- DERIVEDRosenberg AR, Bradford MC, Junkins CC, Taylor M, Zhou C, Sherr N, Kross E, Curtis JR, Yi-Frazier JP. Effect of the Promoting Resilience in Stress Management Intervention for Parents of Children With Cancer (PRISM-P): A Randomized Clinical Trial. JAMA Netw Open. 2019 Sep 4;2(9):e1911578. doi: 10.1001/jamanetworkopen.2019.11578. PMID 31532518